Cite
HARVARD Citation
Kantasiripitak, W. et al. (2022). Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases. CPT: pharmacometrics & systems pharmacology. pp. 1045-1059. [Online].